14 funding opportunities found in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest Lowest Award to Highest Highest Award to Lowest
Call for Applications: 2012 Raymond and Maria Floyd Award for Bladder Cancer Research
The Bladder Cancer Advocacy Network (BCAN) is pleased to announce that we are now accepting applications for the 2012 Raymond and Maria Floyd Award for Bladder Cancer Research. This award is made possible by World Golf Hall of Famer Raymond Floyd and his wife, Maria, who have made a six-figure gift to the organization in support of advancing necessary research efforts to help those who have been profoundly affected by bladder cancer, the nation’s 5th most common form of cancer.
This $25,000 grant will cover direct costs associated with a one year bladder cancer-specific research proposal. The purpose of this grant is to advance research that will increase the understanding of bladder cancer risk, biology, prevention, and treatment while encouraging young investigators to pursue a career in bladder cancer research.
BCAN is eager to review all qualified applications, and we encourage you to distribute this grant information to any young researchers interested in investigating bladder cancer.
At the time the application is submitted, applicant must be a resident, graduate student, clinical research fellow, post-doctoral fellow, or junior faculty at an academic facility, teaching hospital or research institution at the time of application. Faculty members are eligible if within the first 5 years of faculty appointment.
The project must be bladder cancer-specific.
Completed applications must be submitted electronically to grants@bcan.org by March 29, 2012. The grant recipient will then be determined by a selection committee comprised of physicians and research specialists in bladder cancer. The award will be announced on or before May 19, 2012, and the grant period will begin on July 15, 2012. The grant recipient will be expected to present results at BCAN’s annual Bladder Cancer Think Tank Meeting in August, 2013.
Please contact BCAN if you have any questions. You can reach us at grants@bcan.org.
Request for Applications: Prostate Cancer Foundation-Honorable A. David Mazzone Special Challenge Award Research Program 2012
The Prostate Cancer Foundation (PCF) is pleased to announce the PCF-Honorable A. David Mazzone Special Challenge Award Research Program 2012.
These two-year awards will provide a total of $1 million per team. Challenge Awards support large-scale research projects. Proposals must be from teams of at least 3 highly experienced investigators capable of providing unique scientific expertise to the solution of a significant problem in prostate cancer research. A team may be assembled from one institution, or several institutions, from across the globe.
These awards focus on funding Treatment Sciences: Investigations of new ideas in man or laboratory support of a high impact clinical investigation.
IMPORTANT:
The online application submission form will go live at www.pcfscience.org after February 15, 2012.
The deadline for application submission is March 16, 2012.
Dr. Howard R. Soule Executive Vice President Chief Science Officer Prostate Cancer Foundation 1250 4th Street Santa Monica, CA 90401
Call for Applications: Summer Undergraduate Research Fellowship Program at the Ernest Mario School of Pharmacy - Rutgers University
The Ernest Mario School of Pharmacy announces the 2012 Summer Undergraduate Research Fellowship (SURF) Program. The program is intended for highly motivated undergraduates interested in a career as a researcher in the pharmaceutical and environmental sciences. Students are provided with an opportunity to conduct full-time research in areas related to Pharmacology and Toxicology, Environmental Health Sciences, Pharmaceutics, Medicinal Chemistry, Chemical Biology, and Clinical Pharmacy Research. The program is open to undergraduate students enrolled at Rutgers or at another university. Student should be sophomores, juniors, or seniors at the time of application. Previous experience performing independent laboratory or clinical research is not required.
This 10-week program will run May 21 through July 27, 2012 and provides a $2,800 stipend. Funding for room and board is not available. Students must be available for the entire 10-week period. Training includes hands-on research conducted in the laboratories or clinical practices of faculty members, round table discussions of research progress, and seminars on research careers and activities of the faculty. Students also participate in career development workshops. At the end of the fellowship, each student will provide a brief oral presentation on his or her summer research project.
To apply to the Summer Research Fellowship Program, the following items are required:
· Completed application form
· College transcripts (current and previously attended universities)
· Personal statement
· Two letters of recommendation
Applications must be typed and submitted in a single envelope. Letters of recommendation should be in sealed envelopes and included in the envelope with the completed application form, transcripts, and personal statement. All application materials must be received/postmarked by February 15, 2012. Only complete applications will be reviewed.
For further information, please contact Dr. Debra Laskin by email at laskin@eohsi.rutgers.edu or Dr. Lauren Aleksunes at aleksunes@eohsi.rutgers.edu. Students selected for the program will begin to be notified March 26, 2012. Students will have 1 week to notify the Program of their intent to participate. Notifications of selected students will be made through April 9, 2012. Students who are not selected will be notified by April 16, 2012.
Note: Pharmacy students selected for the SURF program will be placed into Cycle III for their pharmacy practice experience.
Send completed applications to:
Ms. Cindy Olexsa Dean’s Office Ernest Mario School of Pharmacy Rutgers University 160 Frelinghuysen Road Piscataway, NJ 08854
The SURF Program at the Ernest Mario School of Pharmacy is financially supported by the National Institute of Environmental Health Sciences (1R25ES020721), the American Society for Pharmacology and Experimental Therapeutics, the UMDNJ Graduate School of Biomedical Sciences, and the Dean of the School of Pharmacy.
General Research Areas
Pharmacology, Toxicology and Environmental Health Sciences: neurotoxicology; immunology; inflammatory mechanisms of tissue injury; kidney injury; role of extracellular matrix in development and disease pathology; wound healing; nitric oxide biology; pulmonary toxicology, developmental toxicology; environmental health sciences
Medicinal Chemistry: design and synthesis of enzyme inhibitors and prodrugs; synthetic organic chemistry, structure activity relationships, medicinal chemistry
Pharmaceutics: design, development and evaluation of drug delivery systems; biopharmaceutics (drug formulation, drug transport); pharmacokinetics
Chemical Biology: cancer biology and prevention; regulation of tumor cell growth and differentiation
Pharmacy Practice: clinical studies; diabetes, hypertension, and medication therapy management
American Society for Radiation Oncology Residents/Fellows in Radiation Oncology Research Seed Grant
This grant is designed to support residents or fellows who are planning a career focusing primarily on basic science or clinical research. It is designed for the exceptional trainee and implies dedication to a career in research.
You are eligible if:
You show a commitment to a career that focuses primarily on radiation oncology sciences.
Your institution has a well-established research and clinical career development program and qualified faculty in radiation oncology sciences to serve as mentors.
You have identified a mentor with extensive research experience to support your project. Either the mentor or co-mentor should be an ASTRO member.
Three grants of up to $25,000 each will be awarded for one-year projects. No salary support will be provided. The recipients are expected to devote 75 percent of their professional effort toward the goals of this award.
You should fill out the award application and requirements, which will be available in winter 2011/2012.
Applications must be received by ASTRO by March 29, 2012. If the deadline falls on a weekend or holiday, applications are due the next business day.
The start date for the next round of Seed Grants will be July 1, 2012.
American Society for Radiation Oncology Junior Faculty Career Research Training Award
This award was created to stimulate interest in radiation research early in junior faculty’s careers by offering them the opportunity to have focused time for research projects in radiation oncology, biology, physics or outcomes/health services.
You are a board-eligible physician or physicist in radiation oncology or a radiobiologist within the first three years of your junior faculty appointment.
Your institution is recognized as providing a rich environment for career development and possesses qualified faculty in clinical, translational or basic research to serve as mentors.
You have found a primary mentor who, together with you, is responsible for the planning, direction and execution of the program.
In addition, the mentor and a responsible member of the institution/department must demonstrate, in writing, a commitment to your development as a productive, independent investigator.
Each year, two junior faculty are selected for this award, which provides $100,000 annually for two years. The second year of funding is contingent upon the recipient meeting all the award requirements at the completion of the first year. A third year of support may be available, but it is competitive with new applicants.
At least 75 percent of the recipient’s full-time professional effort must be devoted to the goals of this award. The remainder may be devoted to clinical, teaching or other research pursuits consistent with the objectives of the award. The successful candidate is expected, toward the end of the award period, to apply for grant support through NIH or other national funding mechanisms, such as K08, K23 or equivalent awards.
Applications for the Junior Faculty Career Research Training Award should be received by ASTRO’s Research Department by March 29, 2012. If the deadline falls on a weekend or holiday, applications are due the next business day.
The start date for 2012 awards will be July 1.
Damon Runyon Clinical Investigator Award
Application deadline date for this award: February 15, 2012
The Damon Runyon Clinical Investigator Award supports young physician-scientists conducting patient-oriented cancer research. The goal is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient’s bedside in search of breakthrough treatments.
The Clinical Investigator Award responds to three recognized realities:
Though there has never been a more pressing need or more promising time for clinical cancer research, fewer young physicians enter this area of investigation every year. The number of institutions committed to training young physicians in the scientific discipline and methodologies of clinical investigation is critically low. The burden of medical school debt (averaging over $100,000) discourages many physicians from pursuing clinical investigation.
The Damon Runyon Cancer Research Foundation’s award offers solutions to these realities. The awardee will receive financial support for three years, as well as assistance with certain research costs such as the purchase of equipment. The Foundation will also retire up to $100,000 of any medical school debt still owed by the awardee.
Building on the long-term success of the Damon Runyon Postdoctoral Fellowships, the creation of the Clinical Investigator Award is a logical extension of the Foundation’s overall mission to defeat cancer. The Clinical Investigator Award program is specifically intended to provide outstanding young physicians with the resources and training structure essential to becoming successful clinical investigators.
Definition of Clinical Research
For the purposes of this award, the Foundation’s definition of clinical research will follow the definition set out in “The NIH Director’s Panel on Clinical Research Report to The Advisory Committee to The NIH Director,” December, 1997.
a) Patient-oriented research: Research conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator directly interacts with human subjects. This area of research includes: patient-based studies of mechanisms of human disease, diagnostic and therapeutic interventions, clinical trials and development of new technologies for the detection, treatment and prevention of human cancers. b) Epidemiologic and behavioral studies. c) Outcomes research and health services research.
Excluded from this definition are in vitro studies that utilize human tissues but do not deal directly with patients. In other words, clinical or patient-oriented research is research in which it is necessary to know the identity of the patient(s) from whom the cells or tissues under study are derived.
Preference will be given to research that adheres to the “Handshake Rule,” meaning that the physician will conduct research studies that directly involve patients.
Partnership with NIH and NCI
Damon Runyon has a novel partnership with the National Institutes of Health (NIH) and the National Cancer Institute (NCI), which uniquely opens access to the NIH Clinical Center (CC) to Damon Runyon Clinical Investigators. The goal of this partnership is to use the special talent, expertise and resources of the participants to undertake pilot studies of specific diseases and to develop collaborative partnerships that accelerate clinical and translational cancer research, and thereby improve human health.
Potential opportunities for pilot partnership:
1. Damon Runyon Clinical Investigator Award applicants may apply with a mentor or co-mentor from NCI or another NIH Institute. The proposal must identify the research to be done at and resources to be used at the NIH CC.
2. Current Damon Runyon Clinical Investigators may conduct a research project at the NIH CC in collaboration with an NIH tenured/tenure-track investigator. The Damon Runyon Clinical Investigator would be the PI or co-PI on the project.
3. Current Damon Runyon Clinical Investigators may request to use the special equipment or facilities at the NIH CC, which could provide opportunities for investigators that may not be possible in their home institutions. Examples are: obtaining research materials such as research PET ligands or products from the CC Good Manufacturing Practice (GMP) facilities, or accessing other non patient-related activities/facilities. No NIH scientist collaboration would be required.
Please contact the Foundation’s Chief Scientific Officer, Yung Lie, with any questions regarding NIH/NCI partnership opportunities (212.455.0521).
Research, Training and Development
During each year of the award, the applicant must commit a minimum of 80% of their full-time professional effort to the conduct of research and research career development.
The Mentor’s role is to foster the development of the applicant’s knowledge, technical and analytical skills, and capacity for scientific inquiry in the field of human disease-oriented clinical and translational research. The Mentor also acts as an advocate for the applicant at the departmental, institutional, and professional levels. Selection and Review
The Clinical Investigator Award Committee (CIAC) will review applications and select awardees for approval by the Damon Runyon Cancer Research Foundation's Board of Directors. CIAC puts a premium on innovation and creativity when reviewing applications.
Selection Criteria
Excellence of the applicant and mentor. Innovation, creativity, quality and originality of the research proposal. The commitment of the mentor and institution to the development and training of the applicant as a skilled clinical research investigator. Evidence of the applicant’s commitment to clinical translational and/or cancer prevention research and their ability to apply advances in laboratory research to clinical problems. Importance of the proposed research to the field of cancer and/or cancer prevention. Adherence of the proposal to the definition of clinical research as set out on this web page. Adherence to the “Handshake Rule.”
Program Sponsors
Under the leadership of the Damon Runyon Cancer Research Foundation, the Clinical Investigator Award is funded in part through Accelerating Cancer Cures, a collaboration of the biopharmaceutical industry, academia and young researchers formed to achieve breakthroughs against cancer by rebuilding the ranks of brilliant and committed clinical investigators who can translate science into cures. Members include: Eli Lilly and Company, Celgene, Merck, Millennium: The Takeda Oncology Company, Pfizer and The Pharmaceutical Research and Manufacturers of America (PhRMA).
Eligibility
The applicant must be a U.S. citizen or permanent legal resident. Each applicant must be nominated by his/her institution. Applications will only be accepted from institutions that have been invited to submit them by the Foundation http://www.damonrunyon.org/for_scientists/more/invited_institutions/
Three (3) nominations per institution, including its affiliated schools, will be accepted. Because of its number of affiliated hospitals, Harvard Medical School may submit up to six (6) nominations.
The applicant must have received an MD or MD/PhD degree(s) from an accredited institution and be board-eligible.
The applicant may apply within the first four (4) years of his/her initial full faculty appointment after the final year of his/her subspecialty training (Adjunct or acting positions are not eligible).
Candidates may apply up to three times during this eligibility period. Candidates holding or awarded R01s at the time of application are not eligible to apply.
The applicant must commit to spending 80% of their time conducting research.
The applicant is required to apply in conjunction with a Mentor who is established in the field of clinical translational cancer research, cancer prevention and/or epidemiology and can provide the critical guidance needed during the period of the award. No more than two Damon Runyon Clinical Investigators will be funded to work with the same Mentor at any given time.
Funding
The $450,000 award will be for a period of three years. Funding in the amount of $150,000 will be allocated to the awardee’s institution each year for the support of the Clinical Investigator. Funds are intended to be flexible and can be used for a variety of scientific needs including the Investigator’s stipend and/or fringe benefits (up to $100,000), salaries for professional and technical personnel, special equipment, supplies and other miscellaneous items required to conduct the proposed research. No part of this grant can be used for indirect costs or institutional overhead.
Other Funding
Investigators may receive funding from other sources to support their research. However, no other physician-scientist career development award from a private source (non-federal government) may be held concurrently with the Clinical Investigator Award.
Physician-scientist career development awards from the federal government including the National Institutes of Health (e.g., K-08, K-12, K-23), the Department of Defense, and the U.S. Department of Veterans Affairs are allowed.
Scientific or budgetary overlap with other funded projects is not allowed. Therefore, it is critical that all current and pending grant support for your research be reported to the Foundation and the relationship of that support to the Damon Runyon funded project be explained.
Examples of awards that cannot be held concurrently with the Damon Runyon Clinical Investigator Award include (but are not limited to):
AACR- Career Development Award American Cancer Society- Mentored Research Scholar Grants in Applied and Clinical Research ASCO- Career Development Award Burroughs Wellcome Fund- Career Award for Medical Scientists Doris Duke Charitable Foundation- Clinical Scientist Development Award Howard Hughes Medical Institute- Physician-Scientists Early Career Award, Early Career Scientist Competition Kimmel Foundation- Kimmel Translation Science Award, Kimmel Scholar Award Leukemia and Lymphoma Society- Career Development Program, Scholar Awards
Please contact the Foundation with any questions regarding concurrent funding (212.455.0520). Debt Repayment Program
The Damon Runyon Cancer Research Foundation will retire up to $100,000 of any qualifying medical school debt still owed by the awardee.
Contact Information: Award Programs | 212.455.0520 | awards@damonrunyon.org
Call for Applications: Dr. Josef Steiner Cancer Research Award 2013
The Dr. Josef Steiner Cancer Foundation announces that it is accepting applications for the 2013 Cancer Research Award. The award consists of financial support for a cancer-related research project in the maximal amount of CHF 1'000'000.- over four years and, in addition, a personal prize in the amount of CHF 50'000.- awarded to the successful principal investigator. The award and price will be presented to the successful candidate in October 2013 at a public ceremony at the University of Bern, Switzerland.
With this award it is the intent of the Dr. Josef Steiner Cancer Foundation to support an outstanding project by an innovative investigator early in her or his career. Projects in both basic research and clinical investigations (translational research) are eligible. The award money may be used for salaries of project co-investigators or staff, equipment and any other costs related to the project. The funds cannot be used to support the salary of the principal investigator. The applicant must provide evidence of his professional affiliation and current position as well as of the availability of the infrastructure needed to carry out the proposed project.
The award money is provided in four annual instalments. The Foundation makes the last three payments conditional upon submission of a yearly progress report. Representatives of the Foundation may visit the research group once during the four-year award period. Under no circumstances can the support be extended beyond four years. The Foundation expects written acknowledgments of its support on all reports published. Evaluation Procedure
The evaluation for the 2013 Prize will take place in three steps. Candidates must first submit a project outline on the official application forms which can be downloaded from www.steinerstiftung.unibe.ch. The completed application and requested documents must be submitted to the president of the Foundation by e-mail with a single attached PDF file. The applications will then be evaluated by the Scientific Advisory Board of the Foundation. The applicants of the best five to six submissions will be invited to submit a detailed research project. These projects will again be evaluated by the Scientific Advisory Board with the additional help of outside referees. The short-listed candidates will be invited for an interview. The final decision on the successful applicant will be made on the recommendation of the Scientific Advisory Board by the Council of the Foundation.
Deadline for submission of the project outline: March 31st 2012.
The five to six successful applicants will be notified by the Foundation not later than June 30th 2012. Deadline for submission of detailed research project: August 31st 2012.
The interviews will take place in January, 2013 in Bern, Switzerland.
The Prize Winner will be notified by the Foundation not later than January 31st 2013. The research work should start between February and December 2013.
Objectives of the Dr. Josef Steiner Cancer Research Foundation
The objectives of the Dr. Josef Steiner award are:
to honor outstanding cancer research: new basic concepts, new diagnostic or therapeutic approaches and preventive methods;
to encourage those individuals who have contributed to basic knowledge of cancer by their systematic research work;
to educate the public that cancer research progress is realized in a step by step manner;
to honor even small advances in the hope that a major breakthrough in cancer research will sooner or later occur.
Funderburg Research Award in Gastric Cancer
One award is made to support the research of an established investigator working on novel approaches to gastric cancer.
AT A GLANCE Eligibility: Established Investigators Total Amount: $100,000 Amount per year: $50,000 Duration: 2 years Deadline: Aug. 31 Start Date: Jan. 1
DESCRIPTION This award provides $50,000 per year for two years (total $100,000) to an established investigator working on novel approaches in gastric cancer research, including the fields of gastric mucosal cell biology; regeneration and regulation of cell growth (not as they relate to peptic ulcer disease or repair); inflammation (including Helicobacter pylori) as precancerous lesions; genetics of gastric carcinoma; oncogenes in gastric epithelial malignancies; epidemiology of gastric cancer; etiology of gastric epithelial malignancies; or clinical research in the diagnosis or treatment of gastric carcinoma.
OBJECTIVE The overall objective of this award is to support an established investigator in the field of gastric biology whose research will enhance the fundamental understanding of gastric cancer pathobiology in order to ultimately prevent or develop a cure for the disease.
ELIGIBILITY Candidates for this award must hold a full-time faculty position at an accredited North American institution and must be established as an independent investigator in the field of gastric biology.
Women and minority investigators are strongly encouraged to apply.
AGA membership is required at the time of application submission. Please visit www.gastro.org/membership or call 301-654-2055, extension 651, for membership information.
REQUIREMENTS A letter of recommendation should be provided by the division chief or chair of the department of medicine and should outline support of the candidate and his/her research program.
Funds are to be used for the salary support, equipment and supplies of the investigator to promote his/her research. Indirect costs are not allowed.
Upon receipt of award notification, the recipient must provide institutional approval from the appropriate committee for use of human subjects or animals. If approval is not necessary, the recipient must provide an explanation. Annually, a one-page plain-language progress report, a scientific progress report, a financial report and a list of publications based on the research must be submitted by the award recipient on or before January 31. Second-year funding is contingent upon submission of this documentation.
All publications, presentations and abstracts arising from work funded by this program must acknowledge support from the AGA Research Foundation R. Robert & Sally D. Funderburg Research Award in Gastric Biology.
AWARD OVERLAP If a candidate is granted the award and notified of a comparable award from another agency prior to the first payment of this award, the applicant must select one of the two awards. (i.e. the recipient may not retain both awards).
SELECTION CRITERIA The recipient will be selected based on novelty, feasibility and significance of the proposal. Preference will be given to novel approaches.
REVIEW PROCESS A selection committee composed of members of the AGA Research Awards Panel will review the proposals and determine the award recipient. Funding will commence in January.
APPLICATION PROCESS The application deadline date for this award is Aug 31. The completed application, letters of support or commitment and other documents, as applicable, must be combined into and submitted as one PDF document. The document must be titled by the applicant’s last name and first initial only. Hard copies are not accepted. Please e-mail the application document to awards@gastro.org. The applicant's full name and project title are to be included in the submission e-mail. Please direct all questions to the Research Awards Manager via telephone at 301-222-4012 or e-mail at awards@gastro.org.
Support for this award by the R. Robert and Sally D. Funderburg Charitable Trust is gratefully acknowledged.
James S. McDonnell Foundation Research Awards for Brain Cancer Research
Investigator-initiated research awards providing up to $450,000 for up to 6 years made to 501(c)(3) organizations in support of work done in Brain Cancer Research.
Deadline: March 14, 2012 15:59 CT. Apply online beginning February 15th.
21st Century Research Awards are designed to support research projects with a high probability of generating new knowledge and insights. Projects submitted for funding consideration should be at an early, even preliminary stage of development, and should be intended to break new ground or to revisit commonly-held assumptions. Projects submitted should be sufficiently cross-disciplinary or heterodox to have a strong likelihood of influencing the development of new ways of thinking about important problems.
21st Century Research Awards provide adequate, flexible funding over a sufficient time period to allow investigators to pursue and develop new directions to their research programs.
A maximum of $450,000 total costs can be requested and the funds can be expended over a minimum of 3 years to a maximum of 6 years. Please Note: Smaller amounts of money expended over shorter amounts of time may be requested to help investigators pursue pilot projects or test the feasibility of an experimental approach.
The applicant can apply the grant funds towards any research-based expense, including travel, equipment, and supplies. Funds can be used to support collaborative research projects. A percentage of the funds can also be used to support small workshops organized by the applicant where the goal of the workshop is to gather expertise in support of the research objective.
Grantee institutions must agree to waive all indirect and administrative costs.
Representatives of the Foundation will not advise applicants on the scientific merits or how well proposed projects fit the goals of JSMF grant programs. We believe these decisions are best made by potential applicant institutions after careful review all JSMF web-posted materials. All projects must qualify for one of the 21st Century Science Initiative's program area (see below) awarding 21st Century Initiative Research Awards.
Brain Cancer Research
The James S. McDonnell Foundation 1034 South Brentwood Blvd., Suite 1850 Saint Louis, MO 63117-1284 (314) 721-1532
NOTE: All applications and letters of inquiry should be sent electronically.
Travel Awards for Young Investigators and Developing Nations Investigators for the 15th World Conference on Lung Cancer
Travel Awards will be available for Young Investigators (35 years of age or younger) and Developing Nations Investigators. These awards will consist of complimentary registration to the Conference, up to five nights accommodation at one of the Conference contracted hotels, a fixed amount to help offset travel expenses and free membership in the International Association for The Study of Lung Cancer for one year.
If you fulfill all criteria for both awards, you may apply for both; however, if selected, you will only be offered one award.
HOW TO APPLY
The candidate must be the first author and presenter of the submitted abstract
Parts of the work can be presented prior to the 15th World Conference on Lung Cancer, but the submitted abstract MUST include new information not being presented prior to WCLC 2013
Abstracts must be submitted on or before the submission deadline June 21, 2013 via the online abstract submission form on the Conference website at www.2013worldlungcancer.org
Candidates must apply at the time of abstract submission via the online submission form on or before June 21, 2013. In addition the following support materials must be sent via email to the Conference Secretariat at wclc2013@icsevents.com. Please indicate your abstract number in your application materials.
Support Materials required for Young Investigator Award Application
Proof of age (35 years of age or younger) Curriculum Vitae Statement by the senior member (who must be a member of the IASLC) of the candidate's role in the research
Support Materials required for Developing Nations Award Application
Curriculum Vitae Description of your interest and current research in lung cancer (1 - 5 pages)
DEADLINES
The deadline for submission of applications including support materials is June 21, 2013. Applications received after June 21, 2013 or applications received without support materials by June 21, 2013 cannot be considered.
CONTACT
For any inquiries, please contact wclc2013@icsevents.com.
12next
